logo-loader
viewPan African Resources plc

Pan African Resources Plc - Director/PDMR Shareholding

Pan African Resources Plc - Director/PDMR Shareholding

Pan African Resources Plc - Director/PDMR Shareholding

PR Newswire

Pan African Resources PLC

(Incorporated and registered in England and Wales under Companies Act 1985 with registered number 3937466 on 25 February 2000)

AIM Code: PAF

JSE Code: PAN

ISIN: GB0004300496

("Pan African" or the “Company”)

DIRECTOR’S DEALINGS IN SECURITIES

DEALING NOTIFICATION FORM
FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

1.  Details of the person discharging managerial responsibilities/person closely associated
a) Name: Charles Needham
2.  Reason for the notification
a) Position/status: Independent non-executive director
b) Initial notification/Amendment: Initial notification
3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Company name: Pan African Resources PLC
b) LEI: 213800EAXURCXMX6RL85
4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument: Ordinary shares of 1p each

Identification code: GB0004300496
b) Nature of the transaction: Acquisition of ordinary shares
c) Price(s) and volume(s):

 
25,000 ordinary shares
High: R2.26
Low: R2.25
VWAP: R2.25
d) Aggregated information: R56,266
e) Date of the transaction: 25 September 2019
f) Place of the transaction: Johannesburg Stock Exchange

Additional information disclosed in accordance with the JSE Listings Requirements:

a) Nature of interest of executive: Beneficial
b) On-market or off-market: On-market
c) Clearance given in terms of paragraph 3.66 of the JSE Listings Requirements: Yes
d) Holding following transactions: 25,000

Johannesburg

25 September 2019

Quick facts: Pan African Resources plc

Price: 10.66

Market: AIM
Market Cap: £205.56 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Faron Pharma encouraged by Clevegen efficacy and tolerability

Top stories from the Proactive Investors UK newsroom. Faron Pharmaceuticals (LON:FARN) has reported increased immune cell activity in its ongoing phase I/II trial of solid tumour cancer treatment Clevegen. All nine patients treated also tolerated high dose levels. South African gold...

on 12/7/19